Somatic mutations in CDH10, expressed predominantly in the brain and involved in synaptic adhesions and axon growth and guidance [40], are associated with colorectal, gastric, and lung cancer and are considered driver mutations in pancreatic cancer [41]. Here, CDH10 is linked to lung cancer.